Skip to main content
ADC Therapy Treatment HER2+ and HER2-Low mBC

Care Team and Patient Resources and Tools for mBC

Videos - Interview with the Innovators

The fifth video includes some suggested mBC resources and tools the panel utilizes to educate themselves, their colleagues, and patients.

Tajuana Bradley, MS, FNP-BC
Nurse Practitioner
Georgia Cancer Specialists
Atlanta, GA
Ryan Haumschild, PharmD, MS, MBA
Director of Pharmacy Services
Emory Healthcare and Winship
Cancer Institute
Atlanta, GA
Abbey J. Kaler, MS, APRN, FNP-C
Supervisor,
Advanced Practice Providers, Advanced Breast Cancer (ABC) Program
The University of Texas MD Anderson Cancer Center
Houston, TX
Susie Ulloa, RN, OCN, ONN-CG
Oncology Nurse Navigator
APT. Inc.
Gainesville, FL

Interview with the Innovators Presents:
Antibody Drug Conjugate Therapy for the Treatment of HER2+ and HER2-Low mBC

As the breast cancer landscape continues to evolve with new research, it is imperative for advance practice providers and nurse navigators to have a comprehensive understanding of the disease state and side effect management. This educational series is intended to enhance the knowledge of advanced practice providers and navigators around a treatment option now available to a new patient population with mBC. The publishers of JONS and JHOP are pleased to present this 6-part video series featuring expert commentary:

Related Items
Ovarian Function Suppression in Premenopausal Women with HR+ Breast Cancer
Emily M. Beard, RN, BSN, OCN, CBCN, Abbey J. Kaler, MS, APRN, FNP-C, Mohammed A. Jaloudi, MD
Best Practices in Ovarian Function Suppression in Breast Cancer published on December 21, 2023 in Breast Cancer
New Developments on Prognostic Markers for Patients With Early Breast Cancer
Nadia Harbeck, MD, PhD
Videos published on December 19, 2023 in Interview with the Innovators
Evolving Adjuvant Treatment Landscape for HR+/HER2- Early Breast Cancer
Nadia Harbeck, MD, PhD
Videos published on December 18, 2023 in Interview with the Innovators
Educating on HER2-Low mBC
Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG
Videos published on November 27, 2023 in Interview with the Innovators
Fostering Shared Treatment Decision-Making
Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG
Videos published on November 27, 2023 in Interview with the Innovators
Setting Appropriate Patient Goals of Therapy
Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG
Videos published on November 27, 2023 in Interview with the Innovators
Managing Patient Expectations and ADC-Related Side Effects
Tajuana Bradley, MS, FNP-BC, Ryan Haumschild, PharmD, MS, MBA, Abbey J. Kaler, MS, APRN, FNP-C, Susie Ulloa, RN, OCN, ONN-CG
Videos published on November 27, 2023 in Interview with the Innovators
A New Era of Treatment Options for Patients with Advanced Renal-Cell Cancer
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Videos published on November 1, 2021 in Interview with the Innovators
Quality of Life with Combination Therapy in Advanced Renal-Cell Cancer
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Videos published on October 8, 2021 in Interview with the Innovators
The Impact of Real-World Data on Efficacy and Safety of Agents for Advanced Renal-Cell Cancer
Megan Price, MSN, APRN, FNP-C, Virginia Seery, MSN, RN, ANP-BC, AOCNP, Laura Wood, RN, MSN, OCN
Videos published on September 24, 2021 in Interview with the Innovators